CSIMarket
 


Reshape Lifesciences Inc   (RSLS)
Other Ticker:  
 
 

RSLS's Revenue Growth by Quarter and Year

Reshape Lifesciences Inc 's Revenue results by quarter and year




RSLS Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 3.11 3.14 3.21
III Quarter September 2.16 2.80 3.71 3.60
II Quarter June 2.19 2.89 3.53 1.70
I Quarter March 2.29 2.44 3.22 2.79
FY   6.64 11.24 13.60 11.30



RSLS Revenue third quarter 2023 Y/Y Growth Comment
Reshape Lifesciences Inc reported decline in Revenue in the third quarter 2023 by -23.04% to $ 2.16 millions, from the same quarter in 2022.
The contraction in the third quarter 2023 Reshape Lifesciences Inc 's Revenue compares unfavorably to the Company's average Revenue doubling of 159.24%.

Looking into third quarter 2023 results within Medical Equipment & Supplies industry 113 other companies have achieved higher Revenue growth. While Reshape Lifesciences Inc ' s Revenue fall of -23.04% ranks overall at the positon no. 2307 in the third quarter 2023.




RSLS Revenue ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - -0.96 % -2.18 % -20.74 %
III Quarter September -23.04 % -24.53 % 3.06 % 2.27 %
II Quarter June -24.22 % -18.13 % 107.65 % -61.8 %
I Quarter March -6.15 % -24.22 % 15.41 % -9.12 %
FY   - -17.35 % 20.35 % -25.12 %

Financial Statements
Reshape Lifesciences Inc 's third quarter 2023 Revenue $ 2.16 millions RSLS's Income Statement
Reshape Lifesciences Inc 's third quarter 2022 Revenue $ 2.80 millions Quarterly RSLS's Income Statement
New: More RSLS's historic Revenue Growth >>


RSLS Revenue (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - 11.07 % -15.36 % -10.83 %
III Quarter September -1.6 % -3.11 % 5.1 % 111.76 %
II Quarter June -4.37 % 18.44 % 9.63 % -39.07 %
I Quarter March -26.37 % -22.29 % 0.31 % -31.11 %
FY (Year on Year)   - -17.35 % 20.35 % -25.12 %




Revenue third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #114
Healthcare Sector #375
Overall #2307

Revenue Y/Y Growth Statistics
High Average Low
2387.02 % 159.24 % -55.07 %
(Dec 31 2019)   (Dec 31 2018)
Revenue third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #114
Healthcare Sector #375
Overall #2307
Revenue Y/Y Growth Statistics
High Average Low
2387.02 % 159.24 % -55.07 %
(Dec 31 2019)   (Dec 31 2018)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Reshape Lifesciences Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
286.87 % 21.63 % -100 %
(Sep 30 2017)  


RSLS's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2023 Reshape Lifesciences Inc disclosed decrease in Revenue from the previous quarter by -1.6% to $ 2.16 millions, from $ 2.19 millions achived a quarter before.

If you evaluate present shortcoming in the quarter, you must take into consideration, that frequently III. Quarter 2023 results emerge sluggish in contrast to the preciding period, Kobe Martin, a business advisor mentioned.

Within Medical Equipment & Supplies industry 79 other companies have achieved higher Revenue quarter on quarter growth. While Reshape Lifesciences Inc 's Revenue growth quarter on quarter, overall rank is 2034.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #80
Healthcare Sector #338
Overall #2034
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #80
Healthcare Sector #338
Overall #2034
Revenue Q/Q Growth Statistics
High Average Low
286.87 % 21.63 % -100 %
(Sep 30 2017)  


RSLS's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2023 Reshape Lifesciences Inc realized decrease in Revenue from the second quarter by -1.6% to $ 2.16 millions, from $ 2.19 millions achived a quarter before.

When you evaluate current downturn in the III. Quarter 2023, you must presume, that commonly III. Quarter performance appear to be softer relative to the second quarter, Kobe Martin, a business advisor said.

Within Medical Equipment & Supplies industry 79 other companies have achieved higher Revenue quarter on quarter growth. While Reshape Lifesciences Inc 's Revenue growth quarter on quarter, overall rank is 2034.


Reshape Lifesciences Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Revenue 12 Months Ending $ 9.75 $ 10.39 $ 11.09 $ 11.24 $ 11.27
Y / Y Revenue Growth (TTM) -13.54 % -14.72 % -13.51 % -17.35 % -17.51 %
Year on Year Revenue Growth Overall Ranking # 2638 # 2061 # 1609 # 1166 # 2621
Seqeuential Revenue Change (TTM) -6.19 % -6.3 % -1.36 % -0.28 % -7.47 %
Seq. Revenue Growth (TTM) Overall Ranking # 2307 # 1912 # 2566 # 2680 # 2981




Cumulative Revenue growth Comment
Reshape Lifesciences Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Jun 30 2023. If the fiscal year would end in Sep 30 2023, Reshape Lifesciences Inc 's annual Revenue decrease would be -13.54% year on year to $10 millions.

In the Healthcare sector 404 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2061 to 2638.

Revenue TTM Q/Q Growth Statistics
High Average Low
2387.02 %
159.24 %
-55.07 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 114
Healthcare Sector # 405
Overall # 2638

Revenue TTM Y/Y Growth Statistics
High Average Low
2387.02 %
159.24 %
-55.07 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 114
Sector # 375
S&P 500 # 2307
Cumulative Revenue growth Comment
Reshape Lifesciences Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Jun 30 2023. If the fiscal year would end in Sep 30 2023, Reshape Lifesciences Inc 's annual Revenue drop would be -13.54% year on year to $10 millions.

In the Healthcare sector 404 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2061 to 2638.

Revenue TTM Q/Q Growth Statistics
High Average Low
2387.02 %
159.24 %
-55.07 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 114
Healthcare Sector # 405
Overall # 2638

Revenue TTM Y/Y Growth Statistics
High Average Low
2387.02 %
159.24 %
-55.07 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 114
Sector # 375
S&P 500 # 2307




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
RSLS's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for RSLS's Competitors
Revenue Growth for Reshape Lifesciences Inc 's Suppliers
Revenue Growth for RSLS's Customers

You may also want to know
RSLS's Annual Growth Rates RSLS's Profitability Ratios RSLS's Asset Turnover Ratio RSLS's Dividend Growth
RSLS's Roe RSLS's Valuation Ratios RSLS's Financial Strength Ratios RSLS's Dividend Payout Ratio
RSLS's Roa RSLS's Inventory Turnover Ratio RSLS's Growth Rates RSLS's Dividend Comparisons



Companies with similar Revenue drop for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2023
Procyon Corporation-0.22%$ -0.221 millions
Amedisys Inc -0.31%$ -0.314 millions
Karyopharm Therapeutics Inc -0.38%$ -0.376 millions
Establishment Labs Holdings Inc -0.50%$ -0.505 millions
Opko Health Inc -0.64%$ -0.639 millions
Integra Lifesciences Holdings Corp-0.72%$ -0.719 millions
Healthcare Services Group Inc -0.75%$ -0.748 millions
Phibro Animal Health Corporation-0.77%$ -0.772 millions
Bellicum Pharmaceuticals Inc -0.89%$ -0.890 millions
Prestige Consumer Healthcare Inc -1.12%$ -1.125 millions
Sharecare Inc -1.13%$ -1.127 millions
Lifevantage Corp-1.14%$ -1.140 millions
Organon and Co -1.17%$ -1.171 millions
Optinose Inc -1.27%$ -1.270 millions
Baxter International Inc -1.72%$ -1.723 millions
Puma Biotechnology Inc -1.73%$ -1.727 millions
Blueprint Medicines Corporation-1.76%$ -1.763 millions
Standard Biotools Inc -1.92%$ -1.918 millions
Pacira Biosciences inc -2.11%$ -2.114 millions
Bristol myers Squibb Company-2.25%$ -2.246 millions
Aurinia Pharmaceuticals Inc -2.27%$ -2.266 millions
Abbott Laboratories-2.56%$ -2.565 millions
Enhabit Inc -2.79%$ -2.785 millions
Novocure Limited-2.81%$ -2.807 millions
Uniqure N v -2.90%$ -2.899 millions
Vaso Corporation-2.92%$ -2.925 millions
Scientific Industries Inc -3.16%$ -3.165 millions
Akumin Inc -3.21%$ -3.205 millions
Syros Pharmaceuticals Inc -3.32%$ -3.315 millions
Viatris Inc -3.34%$ -3.342 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com